FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ben Ho Park

Research Profile

Disorders

Anatomy

Physiology

Living Beings

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Ashley Cimino-Mathews; Hillary Elwood; PETER ILLEI; Ben Ho Park; Rajni Sharma; Andrea P Subhawong; Janis M Taube; Hind Nassar Warzecha; Pedram Argani
Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas.
Lihua Jin; Ben Ho Park; Wei Wang; Patrick M Woster; Yu Wu; Christin L Hanigan; Robert A Casero
Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner.
Justin Cidado; Ben Ho Park
Targeting the PI3K/Akt/mTOR pathway for breast cancer therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ben Ho Park (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ashley Cimino-Mathews; Hillary Elwood; PETER ILLEI; Ben Ho Park; Rajni Sharma; Andrea P Subhawong; Janis M Taube; Hind Nassar Warzecha; Pedram Argani
Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas.
Human pathology 2013;44(6):959-65.
2013: Lihua Jin; Ben Ho Park; Wei Wang; Patrick M Woster; Yu Wu; Christin L Hanigan; Robert A Casero
Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner.
The Biochemical journal 2013;449(2):459-68.
2012: Justin Cidado; Ben Ho Park
Targeting the PI3K/Akt/mTOR pathway for breast cancer therapy.
Journal of mammary gland biology and neoplasia 2012;17(3-4):205-16.
2012: Alison T Stopeck; Hong Yuen Wong; Sara E Barnato; Ursa Brown-Glaberman; William J Gradishar; Clifford A Hudis; Ben Ho Park; Hope S Rugo
The role of targeted therapy and biomarkers in breast cancer treatment.
Clinical & experimental metastasis 2012;29(7):807-19.
2012: Paula J. Hurley; Robert B Jenkins; LUIGI MARCHIONNI; Rebecca M Miller; Ben Ho Park; Sarah B Peskoe; Elizabeth A Platz; Ashley E Ross; David M Berman; Elai Davicioni; Nicholas Erho; Mercedeh Ghadessi; Bora Gurel; Zhenhua Huang; Brian W Simons; Ismael A Vergara; Edward M Schaeffer
Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(37):14977-82.
2012: Ashley Cimino-Mathews; Angelo M DeMarzo; John H Fetting; Marc K Halushka; Jessica L Hicks; PETER ILLEI; Ben Ho Park; Pedram Argani
Androgen receptor expression is usually maintained in initial surgically resected breast cancer metastases but is often lost in end-stage metastases found at autopsy.
Human pathology 2012;43(7):1003-11.
2012: Michaela J Higgins; Peng Huang; Danijela Jelovac; Stacie C Jeter; KATHLEEN MURPHY; George R Oliver; Penny Powers; Carol Riley; Shannon Slater; Vered Stearns; Antonio C Wolff; Jane Zorzi; Philipp Angenendt; Pedram Argani; Kurtis E Bachman; Evan Barnathan; Brian Blair; Leslie Cope; Frank Diehl; Leisha A Emens; John H Fetting; Joel Greshock; Ben Ho Park
Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(12):3462-9.
2012: Julia A Beaver; Ben Ho Park
The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer.
Future oncology (London, England) 2012;8(6):651-7.
2012: Joseph P Garay; Ben Ho Park
Androgen receptor as a targeted therapy for breast cancer.
American journal of cancer research 2012;2(4):434-45.
2012: Joseph P Garay; John P Gustin; Michaela J Higgins; Danijela Jelovac; Bedri Karakas; HIROYUKI KONISHI; Yuko Konishi; Josh David Lauring; Gloria Lewis; Alan K Meeker; Morassa Mohseni; Patrice J Morin; Abde M Abukhdeir; Pedram Argani; David Peter Cosgrove; Angelo M DeMarzo; Cheryl A Sherman Baust; Andrea Subhawong; Antoun Toubaji; Grace M Wang; Ashani T Weeraratna; Ben Ho Park
The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation.
Breast cancer research : BCR 2012;14(1):R27.
2011: Josh David Lauring; Ben Ho Park
BEAMing sheds light on drug resistance.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(24):7508-10.
2011: Alex J Kuo; Josh David Lauring; Wei Li; Ben Ho Park; Xiaobing Shi; Yuanxin Xi; Barry M Zee; Kaifu Chen; Peggie Cheung; Benjamin A Garcia; Mitomu Kioi; Or Gozani
NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming.
Molecular cell 2011;44(4):609-20.
2011: HIROYUKI KONISHI; Yuko Konishi; Josh David Lauring; Alan K Meeker; Morassa Mohseni; Akinobu Ota; Khola Tahir; Akina Tamaki; Kala Visvanathan; Grace M Wang; Hong Yuen Wong; Abde M Abukhdeir; Sabrina Arena; Pedram Argani; Kurtis E Bachman; Justin Cidado; Rory Cochran; David Peter Cosgrove; Sarah Croessmann; Edward Gabrielson; Joseph P Garay; Amy L Gross; John P Gustin; Lauren Hawkins; Christopher M Heaphy; Michaela J Higgins; Yositaka Hosokawa; Danijela Jelovac; Bedri Karakas; Sivasundaram Karnan; Ben Ho Park
Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(43):17773-8.
2011: Tamara LEVIN Lotan; GEORGES NETTO; Ben Ho Park; Alan W Partin; Siobhan Sutcliffe; Jianfeng Xu; David Esopi; Bora Gurel; Misop Han; Jessica L Hicks; Elizabeth Humphreys; William B Isaacs; Wennuan Liu; Angelo M DeMarzo
PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(20):6563-73.
2011: Gloria H Lewis; Andrea Proctor Subhawong; HIND NASSAR; Russell Vang; PETER ILLEI; Ben Ho Park; Pedram Argani
Relationship between molecular subtype of invasive breast carcinoma and expression of gross cystic disease fluid protein 15 and mammaglobin.
American journal of clinical pathology 2011;135(4):587-91.
2011: Hui-Fang Li; Adam Keeton; Michele Vitolo; Clinton Maddox; Lynn Rasmussen; Judith Hobrath; E Lucille White; Ben Ho Park; Gary A Piazza; Jung-Sik Kim; Todd Waldman
A high-throughput screen with isogenic PTEN+/+ and PTEN-/- cells identifies CID1340132 as a novel compound that induces apoptosis in PTEN and PIK3CA mutant human cancer cells.
Journal of biomolecular screening 2011;16(4):383-93.
2011: Michaela J Higgins; Julia A Beaver; Hong Yuen Wong; John P Gustin; Josh David Lauring; Joseph P Garay; HIROYUKI KONISHI; Morassa Mohseni; Grace M Wang; Justin Cidado; Danijela Jelovac; David Peter Cosgrove; Akina Tamaki; Abde M Abukhdeir; Ben Ho Park
PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cells.
Cancer biology & therapy 2011;11(3):358-67.
2010: Danijela Jelovac; Ben Ho Park
PTEN promoter silencing and Cowden syndrome: the role of epigenetic regulation of KILLIN.
JAMA : the journal of the American Medical Association 2010;304(24):2744-5.
2010: M B Weiss; Michele Vitolo; M Mohseni; D M Rosen; Samuel R Denmeade; Ben Ho Park; David Weber; Kurtis E Bachman
Deletion of p53 in human mammary epithelial cells causes chromosomal instability and altered therapeutic response.
Oncogene 2010;29(33):4715-24.
2010: Morassa Mohseni; Ben Ho Park
PIK3CA and KRAS mutations predict for response to everolimus therapy: now that's RAD001.
The Journal of clinical investigation 2010;120(8):2655-8.
2010: Josh David Lauring; David Peter Cosgrove; S Fontana; J P Gustin; HIROYUKI KONISHI; A M Abukhdeir; J P Garay; M Mohseni; G M Wang; M J Higgins; D Gorkin; M Reis; Bert Vogelstein; K Polyak; M Cowherd; P J Buckhaults; Ben Ho Park
Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations.
Oncogene 2010;29(16):2337-45.
2010: Dilek Colak; Muhammad A Chishti; Al-Bandary Al-Bakheet; Ahmed Al-Qahtani; Mohamed M Shoukri; Malcolm H Goyns; Pinar T Ozand; John Quackenbush; Ben Ho Park; Namik Kaya
Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old.
Molecular cancer 2010;9():146.
2010: Sivasundaram Karnan; Morassa Mohseni; Yuko Konishi; Akina Tamaki; Yoshitaka Hosokawa; Ben Ho Park; HIROYUKI KONISHI
Controversial BRCA1 allelotypes in commonly used breast cancer cell lines.
Breast cancer research and treatment 2010;119(1):249-51.
2009: Michele Vitolo; Michele B Weiss; Marta Szmacinski; Khola Tahir; Todd Waldman; Ben Ho Park; Stuart S Martin; David Weber; Kurtis E Bachman
Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells.
Cancer research 2009;69(21):8275-83.
2009: Michaela J Higgins; Ben Ho Park
Expanding role of bisphosphonates in the management of early breast cancer.
Expert review of anticancer therapy 2009;9(8):1051-4.
2009: Donna E Hansel; Masashi Nakayama; Jun Luo; Abde M Abukhdeir; Ben Ho Park; Charles J Bieberich; Jessica L Hicks; Mario A Eisenberger; William G Nelson; Jacek L Mostwin; Angelo M DeMarzo
Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate.
The Prostate 2009;69(6):603-9.
2009: John P Gustin; Bedri Karakas; Michele B Weiss; Abde M Abukhdeir; Josh David Lauring; Joseph P Garay; David Peter Cosgrove; Akina Tamaki; HIROYUKI KONISHI; Yuko Konishi; Morassa Mohseni; Grace Wang; D Marc Rosen; Samuel R Denmeade; Michaela J Higgins; Michele Vitolo; Kurtis E Bachman; Ben Ho Park
Knockin of mutant PIK3CA activates multiple oncogenic pathways.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(8):2835-40.
2008: John P Gustin; David Peter Cosgrove; Ben Ho Park
The PIK3CA gene as a mutated target for cancer therapy.
Current cancer drug targets 2008;8(8):733-40.
2008: Rebecca J Leary; Jimmy C Lin; Jordan Cummins; Simina Boca; Laura D Wood; DONALD PARSONS; Siân Jones; Tobias Sjöblom; Ben Ho Park; Ramon Parsons; Joseph Willis; Dawn Dawson; James Willson; Tatiana Nikolskaya; Yuri Nikolsky; Levy Kopelovich; Nickolas Papadopoulos; Len A Pennacchio; Tian-Li Wang; Sanford D Markowitz; Giovanni Parmigiani; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(42):16224-9.
2008: Josh David Lauring; Abde M Abukhdeir; HIROYUKI KONISHI; Joseph P Garay; John P Gustin; Qiuju Wang; Robert J Arceci; William Matsui; Ben Ho Park
The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity.
Blood 2008;111(2):856-64.
2008: Abde M Abukhdeir; Michele Vitolo; Pedram Argani; Angelo M DeMarzo; Bedri Karakas; HIROYUKI KONISHI; John P Gustin; Josh David Lauring; Joseph P Garay; Courtney Pendleton; Yuko Konishi; Brian G Blair; Keith Brenner; Elizabeth Garrett-Mayer; Hetty Carraway; Kurtis E Bachman; Ben Ho Park
Tamoxifen-stimulated growth of breast cancer due to p21 loss.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(1):288-93.
2008: Abde M Abukhdeir; Ben Ho Park
P21 and p27: roles in carcinogenesis and drug resistance.
Expert reviews in molecular medicine 2008;10():e19.
2007: Laura D Wood; DONALD PARSONS; Siân Jones; Jimmy Lin; Tobias Sjöblom; Rebecca J Leary; Dong Shen; Simina M Boca; Thomas Barber; Janine Ptak; Natalie Silliman; Stephen Szabo; Zoltan Dezso; Vadim Ustyanksky; Tatiana Nikolskaya; Yuri Nikolsky; Rachel Karchin; Paul A Wilson; Joshua S Kaminker; Zemin Zhang; Randal L. Croshaw; Joseph Willis; Dawn Dawson; Michail Shipitsin; James Willson; Saraswati Sukumar; Kornelia Polyak; Ben Ho Park; Charit L Pethiyagoda; P V Krishna Pant; Dennis G Ballinger; Andrew B Sparks; James Hartigan; Douglas R Smith; Erick Suh; Nickolas Papadopoulos; Phillip Buckhaults; Sanford D Markowitz; Giovanni Parmigiani; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein
The genomic landscapes of human breast and colorectal cancers.
Science (New York, N.Y.) 2007;318(5853):1108-13.
2007: Ben Ho Park; Nancy E Davidson
PI3 kinase activation and response to Trastuzumab Therapy: what's neu with herceptin resistance?
Cancer cell 2007;12(4):297-9.
2007: HIROYUKI KONISHI; Bedri Karakas; Abde M Abukhdeir; Josh David Lauring; John P Gustin; Joseph P Garay; Yuko Konishi; Eike Gallmeier; Kurtis E Bachman; Ben Ho Park
Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
Cancer research 2007;67(18):8460-7.
2007: Bedri Karakas; Ashani T Weeraratna; Abde M Abukhdeir; HIROYUKI KONISHI; John P Gustin; Michele Vitolo; Kurtis E Bachman; Ben Ho Park
P21 gene knock down does not identify genetic effectors seen with gene knock out.
Cancer biology & therapy 2007;6(7):1025-30.
2007: Meihua Sui; Yi Huang; Ben Ho Park; Nancy E Davidson; Weimin Fan
Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death.
Cancer research 2007;67(11):5337-44.
2007: HIROYUKI KONISHI; Josh David Lauring; Joseph P Garay; Bedri Karakas; Abde M Abukhdeir; John P Gustin; Yuko Konishi; Ben Ho Park
A PCR-based high-throughput screen with multiround sample pooling: application to somatic cell gene targeting.
Nature protocols 2007;2(11):2865-74.
2007: M B Weiss; Michele Vitolo; K Baerenfaller; G Marra; Ben Ho Park; Kurtis E Bachman
Persistent mismatch repair deficiency following targeted correction of hMLH1.
Cancer gene therapy 2007;14(1):98-104.
2006: Tobias Sjöblom; Siân Jones; Laura D Wood; DONALD PARSONS; Jimmy Lin; Thomas D Barber; Diana Mandelker; Rebecca J Leary; Janine Ptak; Natalie Silliman; Stephen Szabo; Phillip Buckhaults; Christopher Farrell; Paul Meeh; Sanford D Markowitz; Joseph Willis; Dawn Dawson; James Willson; Adi F Gazdar; James Hartigan; Leo Wu; Changsheng Liu; Giovanni Parmigiani; Ben Ho Park; Kurtis E Bachman; Nickolas Papadopoulos; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu
The consensus coding sequences of human breast and colorectal cancers.
Science (New York, N.Y.) 2006;314(5797):268-74.
2006: Bedri Karakas; Ashani T Weeraratna; Abde M Abukhdeir; Brian G Blair; HIROYUKI KONISHI; S Arena; K Becker; W Wood; Pedram Argani; Angelo M DeMarzo; Kurtis E Bachman; Ben Ho Park
Interleukin-1 alpha mediates the growth proliferative effects of transforming growth factor-beta in p21 null MCF-10A human mammary epithelial cells.
Oncogene 2006;25(40):5561-9.
2006: Abde M Abukhdeir; Brian G Blair; Keith Brenner; Bedri Karakas; HIROYUKI KONISHI; Joselin Lim; Vanita Sahasranaman; Yi Huang; Judith Keen; Nancy E Davidson; Michele Vitolo; Kurtis E Bachman; Ben Ho Park
Physiologic estrogen receptor alpha signaling in non-tumorigenic human mammary epithelial cells.
Breast cancer research and treatment 2006;99(1):23-33.
2006: Yi Huang; Judith C Keen; Allison Pledgie; Laurence J Marton; Tao Zhu; Saraswati Sukumar; Ben Ho Park; Brian G Blair; Keith Brenner; Robert A Casero; Nancy E Davidson
Polyamine analogues down-regulate estrogen receptor alpha expression in human breast cancer cells.
The Journal of biological chemistry 2006;281(28):19055-63.
2006: Bedri Karakas; Kurtis E Bachman; Ben Ho Park
Mutation of the PIK3CA oncogene in human cancers.
British journal of cancer 2006;94(4):455-9.
2005: Judith C Keen; Qun Zhou; Ben Ho Park; Catherine Pettit; Kelly M Mack; Brian G Blair; Keith Brenner; Nancy E Davidson
Protein phosphatase 2A regulates estrogen receptor alpha (ER) expression through modulation of ER mRNA stability.
The Journal of biological chemistry 2005;280(33):29519-24.
2005: Kurtis E Bachman; Jason A Sager; Ian Cheong; Marco Catto; Alberto Bardelli; Ben Ho Park; Bert Vogelstein; Angelo Carotti; Kenneth W Kinzler; Christoph Lengauer
Identification of compounds that inhibit growth of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine-resistant cancer cells.
Molecular cancer therapeutics 2005;4(6):1026-30.
2005: Kurtis E Bachman; Ben Ho Park
Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.
Current opinion in oncology 2005;17(1):49-54.
2004: Kurtis E Bachman; Pedram Argani; Yardena Samuels; Natalie Silliman; Janine Ptak; Stephen Szabo; HIROYUKI KONISHI; Bedri Karakas; Brian G Blair; Clarence Lin; Brock A Peters; Victor E Velculescu; Ben Ho Park
The PIK3CA gene is mutated with high frequency in human breast cancers.
Cancer biology & therapy 2004;3(8):772-5.
2004: Ben Ho Park; Nancy E Davidson
Estrogen receptor status, cell cycling and paclitaxel: looking for a "hormone"-ious explanation.
Cancer biology & therapy 2004;3(5):468-9.
2004: Kurtis E Bachman; Brian G Blair; Keith Brenner; Alberto Bardelli; Sabrina Arena; Shibin Zhou; Jessica Hicks; Angelo M DeMarzo; Pedram Argani; Ben Ho Park
p21(WAF1/CIP1) mediates the growth response to TGF-beta in human epithelial cells.
Cancer biology & therapy 2004;3(2):221-5.
2003: Kurtis E Bachman; Ben Ho Park; Ina Rhee; Harith Rajagopalan; James G Herman; Stephen B Baylin; Kenneth W Kinzler; Bert Vogelstein
Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene.
Cancer cell 2003;3(1):89-95.
2002: Ina Rhee; Kurtis E Bachman; Ben Ho Park; Kam-Wing Jair; Ray-Whay Chiu Yen; Kornel E Schuebel; Hengmi Cui; Andrew P Feinberg; Christoph Lengauer; Kenneth W Kinzler; Stephen B Baylin; Bert Vogelstein
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells.
Nature 2002;416(6880):552-6.
2001: Ben Ho Park; Bert Vogelstein; Kenneth W Kinzler
Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(5):2598-603.
2001: Ben Ho Park; Benjamin Breyer; Tong-Chuan He
Peroxisome proliferator-activated receptors: roles in tumorigenesis and chemoprevention in human cancer.
Current opinion in oncology 2001;13(1):78-83.
2000: Lin Zhang; J Yu; Ben Ho Park; Kenneth W Kinzler; Bert Vogelstein
Role of BAX in the apoptotic response to anticancer agents.
Science (New York, N.Y.) 2000;290(5493):989-92.
1995: D J Marshall; Ben Ho Park; Jonathan Korostoff; Glen N Gaulton
Manipulation of the immune response by foreign gene expression in the thymus.
Leukemia 1995;9 Suppl 1():S128-32.
1994: Ben Ho Park; B Matuschke; Ehud Lavi; Glen N Gaulton
A point mutation in the env gene of a murine leukemia virus induces syncytium formation and neurologic disease.
Journal of virology 1994;68(11):7516-24.
1994: Ben Ho Park; Ehud Lavi; Glen N Gaulton
Intracerebral hemorrhages and infarction induced by a murine leukemia virus is influenced by host determinants within endothelial cells.
Virology 1994;203(2):393-6.
1994: Ben Ho Park; Ehud Lavi; A Stieber; Glen N Gaulton
Pathogenesis of cerebral infarction and hemorrhage induced by a murine leukemia virus.
Laboratory investigation; a journal of technical methods and pathology 1994;70(1):78-85.
1993: Ben Ho Park; Ehud Lavi; Kenneth J Blank; Glen N Gaulton
Intracerebral hemorrhages and syncytium formation induced by endothelial cell infection with a murine leukemia virus.
Journal of virology 1993;67(10):6015-24.
1993: H Koeppen; S Singh; H J Stauss; Ben Ho Park; D A Rowley; Hans Schreiber
CD4-positive and B lymphocytes in transplantation immunity. I. Promotion of tumor allograft rejection through elimination of CD4-positive lymphocytes.
Transplantation 1993;55(6):1349-55.
1991: M N Teng; Ben Ho Park; H Koeppen; Kevin Tracey; B M Fendly; Hans Schreiber
Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(9):3535-9.
1990: G Torre-Amione; R Daniel Beauchamp; H Koeppen; Ben Ho Park; Hans Schreiber; Harold L Moses; D A Rowley
A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(4):1486-90.